Juri Ruf

5.8k total citations
112 papers, 2.9k citations indexed

About

Juri Ruf is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Juri Ruf has authored 112 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Radiology, Nuclear Medicine and Imaging, 50 papers in Pulmonary and Respiratory Medicine and 25 papers in Oncology. Recurrent topics in Juri Ruf's work include Medical Imaging Techniques and Applications (35 papers), Prostate Cancer Treatment and Research (34 papers) and Radiopharmaceutical Chemistry and Applications (30 papers). Juri Ruf is often cited by papers focused on Medical Imaging Techniques and Applications (35 papers), Prostate Cancer Treatment and Research (34 papers) and Radiopharmaceutical Chemistry and Applications (30 papers). Juri Ruf collaborates with scholars based in Germany, Cyprus and Poland. Juri Ruf's co-authors include Holger Amthauer, Timm Denecke, Christian Furth, Ingo G. Steffen, Michail Plotkin, Matthias Gutberlet, Hubertus Hautzel, Günter Henze, Stefan Schönberger and R. Félix and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Juri Ruf

108 papers receiving 2.8k citations

Peers

Countries citing papers authored by Juri Ruf

Since Specialization

Citations

This map shows the geographic impact of Juri Ruf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juri Ruf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juri Ruf more than expected).

Fields of papers citing papers by Juri Ruf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juri Ruf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juri Ruf. The network helps show where Juri Ruf may publish in the future.

Co-authorship network of co-authors of Juri Ruf

This figure shows the co-authorship network connecting the top 25 collaborators of Juri Ruf. A scholar is included among the top collaborators of Juri Ruf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juri Ruf. Juri Ruf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Toxicity and Patient Reported Quality of Life after PSMA-PET and mpMRT-Based Focal Dose Escalated Definitive Radiotherapy in Prostate Cancer Patients: 2-Year Follow-Up of the HypoFocal Phase II Trial 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), (unknown), (unknown), (unknown), August Sigle, Michael Mix, Juri Ruf, (unknown), (unknown), R. Wiehle, (unknown), Matthias Benndorf, Sebastian Zschaeck, Pirus Ghadjar, Dimos Baltas, Simon Kirste, Constantinos Zamboglou, Anca-Ligia Grosu	1
2	[68Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancer 2023 ·Archives of Gynecology and Obstetrics ·Kerstin Michalski, Katharina Müller‐Peltzer, Ingolf Juhasz‐Böss, Philipp T. Meyer, Juri Ruf, (unknown)	3
3	Prognostic value of tumor volume assessment on PSMA PET after [Lu-177]PSMA radioligand therapy evaluated by PSMA PET/CT consensus statement and RECIP 1.0 2023 ·Nuklearmedizin - NuclearMedicine ·(unknown), (unknown), Cordula A. Jilg, Philipp E. Hartrampf, (unknown), Juri Ruf, Kerstin Michalski	3
4	The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation 2022 ·Clinical and Translational Radiation Oncology ·Alexander Rühle, Anca‐L. Grosu, Nicole Wiedenmann, Juri Ruf, (unknown), (unknown), Andreas Thomsen, Eleni Gkika, Peter Vaupel, Dimos Baltas, Wolfgang Weber, Michael Mix, Nils H. Nicolay	2
5	Bone marrow impairment during early [Lu-177]PSMA-617-Radioligand Therapy: hematotoxicity or tumor progression? 2022 ·Nuklearmedizin - NuclearMedicine ·(unknown), Kerstin Michalski, (unknown), (unknown), Michael Mix, Juri Ruf	1
6	18F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy 2021 ·Cancers ·M. Carles, Tobias Fechter, Anca-Ligia Grosu, A Sörensen, (unknown), (unknown), Nicole Wiedenmann, Alexander Rühle, Constantinos Zamboglou, Juri Ruf, Luis Martí‐Bonmatí, Dimos Baltas, Michael Mix, Nils H. Nicolay	26
7	The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging 2021 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), (unknown), Sven Stadlbauer, Mareike Roscher, Wael Khoder, Christian Gratzke, Klaus Kopka, Matthias Eder, Philipp T. Meyer, Cordula A. Jilg, Juri Ruf	27
8	Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [¹⁷⁷Lu]Lu-PSMA-617 2021 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Stephan Maus, Florian Rosar, Juri Ruf, Jason P. Holland, Samer Ezziddin, Mark Bartholomä	18
9	Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report 2021 ·Hereditary Cancer in Clinical Practice ·(unknown), Markus Uhl, Juri Ruf, Tilmann Schumacher, Udo Kontny	2
10	The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer 2020 ·Radiotherapy and Oncology ·Nicole Wiedenmann, Anca-Ligia Grosu, Martin Büchert, Hans Christian Rischke, Juri Ruf, (unknown), (unknown), Alexander Rühle, Fabian Bamberg, Dimos Baltas, Jürgen Hennig, Michael Mix, Michael Bock, Nils H. Nicolay	25
11	1915P The lenvatinib/pembrolizumab combination induces long lasting and complete responses in patients with metastatic anaplastic or poorly differentiated thyroid carcinoma: Results from a retrospective study and first results from the prospective phase II ATLEP trial 2020 ·Annals of Oncology ·Christine Dierks, Jochen Seufert, Juri Ruf, Justus Duyster, Oliver Thomusch, Cornelius Miething, A. Zielke	14
12	Urinary Excretion of Yttrium-90 after Radioembolization with Yttrium-90-Labeled Resin-based Microspheres 2017 ·Health Physics ·Oliver S. Großer, Juri Ruf, (unknown), Dennis Kupitz, (unknown), Christoph Benckert, Maciej Pech, Jens Ricke, Holger Amthauer	5
13	Detektion der obstruktiven Uropathie und Erhebung der seitengetrennten Nierenfunktion mit zwei funktionellen Magnetresonanzurographie-Verfahren 2017 ·Nuklearmedizin - NuclearMedicine ·(unknown), Julian M.M. Rogasch, Ingo G. Steffen, (unknown), Ivayla Apostolova, Juri Ruf, Anke Rißmann, Dagobert Wiemann, (unknown), Martin Schostak, Holger Amthauer, Christian Furth	1
14	Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor 2017 ·Clinical Case Reports ·Stefan Asbach, (unknown), Juri Ruf, Christoph Bode, Corinna N. Lang	0
15	Evaluation of interim PET response criteria in paediatric Hodgkin's lymphoma—results for dedicated assessment criteria in a blinded dual-centre read 2010 ·Annals of Oncology ·Christian Furth, Holger Amthauer, Hubertus Hautzel, Ingo G. Steffen, Juri Ruf, (unknown), Stefan Schönberger, G. Henze, (unknown), Patrick Hundsdoerfer, Markus Dietlein, Carsten Kobe	31
16	Early and Late Therapy Response Assessment With [ ¹⁸ F]Fluorodeoxyglucose Positron Emission Tomography in Pediatric Hodgkin's Lymphoma: Analysis of a Prospective Multicenter Trial 2009 ·Journal of Clinical Oncology ·Christian Furth, Ingo G. Steffen, Holger Amthauer, Juri Ruf, Daniel Misch, Stefan Schönberger, Carsten Kobe, Timm Denecke, B. Stöver, Hubertus Hautzel, Günter Henze, Patrick Hundsdoerfer	96
17	Positron Emission Tomography for Staging of Pediatric Sarcoma Patients: Results of a Prospective Multicenter Trial 2007 ·Journal of Clinical Oncology ·Thomas Völker, Timm Denecke, Ingo G. Steffen, Daniel Misch, Stefan Schönberger, Michail Plotkin, Juri Ruf, Christian Furth, B. Stöver, Hubertus Hautzel, Günter Henze, Holger Amthauer	265
18	Einfluss der Bildfusion und Schwächungskorrektur mittels SPECT-CT auf die szintigraphische Detektion von Nebenschilddrüsenadenomen 2007 ·Juri Ruf, Daniel Seehofer, Timm Denecke, Lars Stelter, Nada Rayes, (unknown), Holger Amthauer	19
19	Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT 2007 ·Nuclear Medicine Communications ·Juri Ruf, Ingo G. Steffen, (unknown), Christian Rosner, Timm Denecke, Ulrich‐Frank Pape, Michail Plotkin, Holger Amthauer	22
20	Detection of infectious colitis by 18F-fluorodeoxyglucose-positron emission tomography in a child receiving intensive care after cardiac surgery 2005 ·Pediatric Radiology ·Juri Ruf, (unknown), Brigitte Stiller, Nanette Sarioglu, Peter Lange, Holger Amthauer	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact